Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

New TMS Center Opening in Wilsonville to Effectively Treat Depression

Achieve TMS
Posted on: 30 Nov 17

WILSONVILLE, Ore., Nov. 29, 2017 /PRNewswire/ -- Achieve TMS, the largest and most experienced provider of deep Transcranial Magnetic Stimulation (dTMS) for the treatment of depression, is opening a third state-of-the-art center in the greater Portland area on January 1, 2018. This new center, located in Wilsonville, Oregon will treat local residents who have major depressive disorder and are unable or unwilling to take medications. Free consultations are now available. Deep TMS (dTMS) treatments are approved by the FDA and covered by nearly every major commercial insurance carrier in the U.S. Allison Hadley MD is Medical Director for Achieve TMS Oregon and also serves on staff at The Unity Center for Behavioral Health in Portland.

"Depression currently ranks as a leading cause of disability. With 1 in 6 Americans suffering from depression there is a huge need for treatments that are proven to make a difference in the battle against this debilitating disease" said Manish Sheth, MD, PhD, founder of Achieve TMS. "Deep Transcranial Magnetic Stimulation (TMS) is known to be an effective tool in the battle. Patients and their families are looking for an effective way to move away from depression into a place where lives are productive, balanced, healthy and well integrated. TMS is a vital tool that helps facilitate healing and we have established a commitment to working in partnership with psychiatrists, psychologists and therapists in the local Wilsonville area to expand access to this treatment option."

Deep TMS works by administering magnetic pulses through an H-coil on the scalp that is targeted to the mood center of the brain. The magnetic fields induce electrical currents that stimulate underactive neurons, helping to reset brain chemistry, resulting in improved sleep, concentration and overall mood. It is safe, non-invasive and highly effective for those who are treatment resistant and/or have experienced no relief from medication.                             

In more than 60 clinical studies globally, dTMS has consistently demonstrated statistically significant response and remission rates. The therapy is well tolerated by patients, causing no adverse effects. Treatment sessions are prescribed five days per week for six weeks, with each session lasting 20 minutes. There is no sedation involved, and no down time.

The new Achieve TMS Center in Wilsonville is located at 8755 S.W. Citizens Drive Suite 203.

Achieve TMS welcomes inquiries about dTMS treatments and is scheduling complimentary consultations and appointments for Wilsonville at this time. For more information please contact Achieve TMS at (877) 391-7019 or visit www.achievetms.com.

For Media Inquiries Contact:

Laura Segall, Chief Marketing Officer

760-533-2784

185470@email4pr.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 30/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.